{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:57Z","timestamp":1791322317089,"version":"4.3.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/rhu.0b013e31823ecbdf","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T07:47:15Z","timestamp":1323762435000},"page":"28-32","source":"Crossref","is-referenced-by-count":46,"title":["Systemic Lupus Erythematosus With Sj\u00f6gren Syndrome Compared to Systemic Lupus Erythematosus Alone"],"prefix":"10.1097","volume":"18","author":[{"given":"Qingping","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy D.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210207","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncprheum0165","article-title":"The management of Sjogrens syndrome.","volume":"2","author":"Mavragani","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R2-5-20210207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-74-1-55","article-title":"The coexistence of Sjogrens syndrome and systemic lupus erythematosus.","volume":"74","author":"Steinberg","year":"1971","journal-title":"Ann Intern Med"},{"key":"R3-5-20210207","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-81-5-577","article-title":". Sjogrens syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations.","volume":"81","author":"Alarcon-Segovia","year":"1974","journal-title":"Ann Intern Med"},{"key":"R4-5-20210207","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1191\/096120398678920046","article-title":"Systemic lupus erythematosus VII: frequency and impact of secondary Sjogrens syndrome.","volume":"7","author":"Nossent","year":"1998","journal-title":"Lupus"},{"key":"R5-5-20210207","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":". Sjogrens syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogrens syndrome.","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R6-5-20210207","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.humimm.2006.06.006","article-title":". Clinical, serologic, and genetic profiles of patients with associated Sjogrens syndrome and systemic lupus erythematosus.","volume":"67","author":"Szanto","year":"2006","journal-title":"Hum Immunol"},{"key":"R7-5-20210207","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10067-007-0720-0","article-title":". Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjogren syndrome in China: a study of 542 patients.","volume":"27","author":"Pan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R8-5-20210207","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0961203309348235","article-title":". Sjogrens syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.","volume":"19","author":"Xu","year":"2010","journal-title":"Lupus"},{"key":"R9-5-20210207","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":". Secondary Sjogrens syndrome in systemic lupus erythematosus defines a distinct disease subset.","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"key":"R10-5-20210207","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R11-5-20210207","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":". Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R12-5-20210207","first-page":"201","article-title":". Sjogrens syndrome in systemic lupus erythematosus.","volume":"17","author":"Andonopoulos","year":"1990","journal-title":"J Rheumatol"},{"key":"R13-5-20210207","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.1780310406","article-title":". Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DRDQ specificities with quantitative expression of Ro (SS-A) autoantibody.","volume":"31","author":"Hamilton","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R14-5-20210207","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI110523","article-title":"Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.","volume":"69","author":"Wasicek","year":"1982","journal-title":"J Clin Invest"},{"key":"R15-5-20210207","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0961203307083365","article-title":". Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients.","volume":"16","author":"Malik","year":"2007","journal-title":"Lupus"},{"key":"R16-5-20210207","first-page":"4003","article-title":"Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus Arthritis Rheum.","volume":"52","author":"To","year":"2005","journal-title":""},{"key":"R17-5-20210207","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/jaut.1996.0110","article-title":". Production of anti-RoSS-A and anti-LaSS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production.","volume":"10","author":"Meilof","year":"1997","journal-title":"J Autoimmun"},{"key":"R18-5-20210207","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/art.1780390321","article-title":"Some autoantibodies to RoSS-A and LaSS-B are antiidiotypes to anti-double-stranded DNA.","volume":"39","author":"Zhang","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R19-5-20210207","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0961203309353172","article-title":". Systemic lupus erythematosus and Sjogrens syndrome induced in a case by interferon- used for the treatment of hepatitis C.","volume":"19","author":"Onishi","year":"2010","journal-title":"Lupus"},{"key":"R20-5-20210207","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/ard.60.10.992","article-title":"Anti-dsDNA antibodies associated with acute EBV infection in Sjogrens syndrome.","volume":"60","author":"Padalko","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R21-5-20210207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/BOR.0b013e32832f0861","article-title":"Genetics of systemic lupus erythematosus and Sjogrens syndrome.","volume":"21","author":"Scofield","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"R22-5-20210207","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":". Variant form of STAT4 is associated with primary Sjogrens syndrome.","volume":"9","author":"Korman","year":"2008","journal-title":"Genes Immun"},{"key":"R23-5-20210207","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":". Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogrens syndrome.","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"R24-5-20210207","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":". In primary Sjogrens syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R25-5-20210207","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":". Clinical evolution, and morbidity and mortality of primary Sjogrens syndrome.","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-201201000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:52Z","timestamp":1786048312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-201201000-00005"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31823ecbdf","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}